Dr. David Antonio Medina, MD

Dr. Medina practices at Nova Psychiatry Inc in Winter Park, Florida.

Dr. Medina's NPI, 1588805824, was assigned on March 17, 2009. Dr. Medina graduated from Central University of Venezuela in 1994. Dr. Medina holds Florida license ME112336.

Dr. Medina's primary practice is Nova Psychiatry Inc, at 438 N Capen Ave, Winter Park, FL 32789 in Orange County. The practice phone is (407) 883-9303.

Dr. Medina's primary practice is Nova Psychiatry Inc in Winter Park, Florida. The medical group on file is NOVA Psychiatry. Dmand AI also links Dr. Medina to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medina practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Medina's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Medina is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Medina's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists ADHD, adjustment disease, anxiety, bipolar disorder, depression, insomnia, intellectual and developmental disabilities and non-alzheimer's dementia (chronic) among the conditions Dr. Medina treats.

CMS data shows 1,352 Medicare services from Dr. Medina across 10 procedure codes in 2024, for 290 Medicare patients. Medicare paid $143,914 for them.

CMS counts 290 Medicare patients who saw Dr. Medina in 2024. The largest group is 85 and over, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Medina's median patient age at 62, with 63% women.

In 2024, Dr. Medina wrote 9,790 Medicare Part D claims for 544 patients. 90% of them were for generic drugs. CMS names the drug for 9,625 of them, across 82 drugs with 11 or more claims each, at $2,066,470 in total drug cost. In 2023, CMS named 9,022 claims across 78 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Medina for performance year 2024, reported individually. Dr. Medina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Medina as offering telehealth.

Dmand AI links 1 paper to Dr. Medina.

Dmand AI links Dr. Medina to 9 clinical trials, 6 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Depressive Disorder, Depressive Disorder, Major and Schizophrenia. Naurex, Inc, an affiliate of Allergan plc sponsors the most, 3.

CMS Open Payments shows 1,166 general payments to Dr. Medina from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Neurocrine BioSciences, Inc. paid the most, $120,864. It also lists 7 research payments totaling $1,544 in 2019.

Dr. Medina graduated from Central University of Venezuela in 1994. Dr. Medina is a member of APA and Florida Psychiatric Society.

Dr. Medina is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.